Oncimmune Holdings Plc

Oncimmune (ONC)

Company name:Oncimmune Holdings Plc
EPIC:ONCTrading Currency:GBX
Market Sector:ASM7ISIN:GB00BYQ94H38
Market Segment:AMSMShare Type:DE
WWW Address:Description:ORD 1P
 Price Price Change [%] Bid Offer Open High Low Volume
 58.10 images.advfn.com/imagesnew/2/gb/down -2.4 [-3.97] 57.20 59.00 58.60 58.60 58.00 49,500
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 40.32 69.40 -0.01 -13.36 - - - 151.00 - 41.00

Oncimmune Key Figures

(at previous day's close)
Market Cap.40.32m
Shares In Issue69.40m
Prev. Close60.50
PE Ratio- 
Dividend Yield-%
EPS - basic-13.36p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-12.83p
Return On Equity (ROE)-%
Operating Margin-1,922.00%
PEG Factor- 
EPS Growth Rate-3.01%
Dividends PS Growth Rate-%
Net Debt6.27m
Gross Gearing101.88%
Quick Assets6.05m
Net Working Capital2.76m
Intangibles / Fixed Assets90.46%
Turnover PS0.73p
Pre-Tax Profit PS-14.10p
Retained Profit PS-12.07p
Cash PS6.11p
Net Cash PS1.11p
Net Tangible Asset Value PS *-5.61p
Net Asset Value PS-0.28p
Spread1.80 (3.05%) 

Oncimmune Balance Sheet


Share Price Performance

Sample Period HighLow
1 week68.0058.00
4 weeks71.0052.10
12 weeks71.0041.00
1 year151.0041.00

Share Price Chart (5 years)

Oncimmune Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week67.20-9.10-13.5458.000.0762.02
4 weeks52.106.0011.5252.100.0563.37
12 weeks44.0014.1032.0541.000.1048.80
26 weeks84.00-25.90-30.8341.000.1772.13
1 year150.00-91.90-61.2741.000.1181.01
3 years35.5022.6063.6631.500.12120.14
5 years131.50-73.40-55.8231.500.09115.15

Oncimmune Key Management Ratios

Oncimmune Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 4.08 
Tobin's Q Ratio (excl. intangibles)6.18 
Dividend Yield-%
Market-to-Book Ratio-207.83 
Price-to-Pre-Tax Profit PS-4.12 
Price-to-Retained Profit PS-4.81 
Price-to-Cash Flow PS-4.53 
Price-to-Sales PS79.21 
Price-to-Net Tangible Asset Value PS-10.36 
Price-to-Cash PS9.51 
Net Working Capital PS3.98 
Price Pct to Working Capital PS14.61%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Oncimmune Financial Ratios

(Leverage Ratios)
Debt Ratio102.83%
Debt-to-Equity Ratio-36.30 
Debt-to-Equity Ratio (excl. Intgbl)-1.81 
Debt-to-Equity Market Value0.17 
Net Gearing60.78%
Net Gearing (excl. Intangibles)94.74%
Gross Gearing101.88%
Gross Gearing (excl. Intangibles)158.82%
Gearing Under 1 Year33.61%
Gearing Under 1 Year (excl. Intgbl)52.40%
(Liquidity Ratios)
Net Working Capital to Total Assets26.76%
Current Ratio1.80 
Quick Ratio (Acid Test)1.75 
Liquidity Ratio1.22 
Cash & Equiv/Current Assets68.09%
(Solvency Ratios)
Enterprise Value43.12m
CFO/Attributable Profit- 
Total Debt/Equity Market Value0.26 
Total Debt/Sales20.65 
Total Debt/Pre-Tax Profit-1.07 
Total Debt10.51m
Total Debt/Net Current Assets3.81%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-10.71%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs3 
Beta (60-Mnth)Beta (36-Mnth)

Oncimmune Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-142.86%
Return On Assets (ROA)-84.83%
Net Profit Margin-1,645.38%
Assets Turnover0.05 
Return On Equity (ROE)-%
Return On Investment (ROI)-110.06%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-1,645.38%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.13 
Fixed Assets Turnover0.14 
Current Assets Turnover0.08 
Net Working Capital Turnover 
Inventory Turnover2.18 
(Other Operating Ratios)
Total Assets-to-Sales19.40 
Debt Collection Period775.18Days

Oncimmune Dividends

Sorry No Data Available

Oncimmune Fundamentals

 31 May 2017 (GBP)31 May 2018 (GBP)31 May 2019 (GBP)31 May 2020 (GBP)
pre tax profit-5.32--6.34--8.55--9.78-m
attributable profit-4.80--6.37--8.03--8.38-m
retained profit-4.80--6.37--8.03--8.38-m
eps - basic (p)-9.84 -11.41 -12.97 -13.36 
eps - diluted (p)-9.84 -11.41 -12.97 -13.36 
dividends per share- - - - 

Oncimmune Balance Sheet

 31 May 2017 (GBP)31 May 2018 (GBP)31 May 2019 (GBP)31 May 2020 (GBP)
 31 May 2017 (GBP)31 May 2018 (GBP)31 May 2019 (GBP)31 May 2020 (GBP)
fixed assets fixed assets0.233.59%0.201.39%0.424.47%0.393.78%m
intangibles intangibles0.528.08%0.674.66%3.0131.92%3.7035.85%m
fixed investments fixed investments--%--%--%--%m
current assets - other current assets - other--%--%--%--%m
stocks stocks0.325.04%0.302.05%0.293.10%0.171.69%m
debtors debtors0.264.07%0.292.02%0.353.70%1.8117.58%m
cash & securities cash & securities5.0879.21%12.9589.88%5.3656.81%4.2441.11%m
creditors - short creditors - short1.4021.90%0.855.89%1.0611.24%3.4733.61%m
creditors - long creditors - long--%--%0.515.37%7.0468.27%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves5.0078.10%13.5694.11%7.8783.40%-0.19-1.88%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Oncimmune Cash Flow Statement

31 May 2017 (GBP)31 May 2018 (GBP)31 May 2019 (GBP)31 May 2020 (GBP)
Operating CF-4.28-6.10-7.36-8.90m
Pre-Financing CF-4.67-6.41-7.52-8.56m
Retained CF-5.097.88-7.60-1.12m

Oncimmune Brokers

Broker infomation is not available for this class of stock.
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20230205 07:20:11